Ali Loukaci

882 total citations
19 papers, 404 citations indexed

About

Ali Loukaci is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Ali Loukaci has authored 19 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Organic Chemistry and 6 papers in Pharmacology. Recurrent topics in Ali Loukaci's work include Marine Sponges and Natural Products (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and Synthesis and Biological Activity (4 papers). Ali Loukaci is often cited by papers focused on Marine Sponges and Natural Products (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and Synthesis and Biological Activity (4 papers). Ali Loukaci collaborates with scholars based in France, Canada and Tunisia. Ali Loukaci's co-authors include Michèle Guyot, Christiane Garbay, Rafika Jarray, Yves Lepelletier, Florence I. Raynaud, Réda Hadj-Slimane, Arlette Longeon, Valérie Bultel‐Poncé, Oliver Kayser and J. Frevert and has published in prestigious journals such as Analytical Biochemistry, Chemical Communications and Phytochemistry.

In The Last Decade

Ali Loukaci

19 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Loukaci France 11 216 139 89 74 52 19 404
Lianne M. McHardy Canada 10 289 1.3× 110 0.8× 101 1.1× 29 0.4× 102 2.0× 11 454
Masahide Amemiya Japan 13 287 1.3× 236 1.7× 87 1.0× 25 0.3× 152 2.9× 31 504
Isao Uno Japan 13 399 1.8× 190 1.4× 78 0.9× 138 1.9× 266 5.1× 31 669
Klaus Feussner Fiji 13 255 1.2× 83 0.6× 91 1.0× 15 0.2× 125 2.4× 18 472
Christos Roussakis France 13 163 0.8× 101 0.7× 112 1.3× 29 0.4× 58 1.1× 30 442
M. Teresa García‐López Spain 11 214 1.0× 185 1.3× 15 0.2× 119 1.6× 21 0.4× 33 416
Kathryn M. Marshall Australia 11 287 1.3× 157 1.1× 143 1.6× 47 0.6× 94 1.8× 17 562
Luke Esau Saudi Arabia 11 200 0.9× 91 0.7× 39 0.4× 21 0.3× 33 0.6× 14 396
A Matsuzaki Japan 4 200 0.9× 158 1.1× 38 0.4× 34 0.5× 104 2.0× 5 404
Koichi Nakae Japan 10 172 0.8× 140 1.0× 42 0.5× 25 0.3× 178 3.4× 15 357

Countries citing papers authored by Ali Loukaci

Since Specialization
Citations

This map shows the geographic impact of Ali Loukaci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Loukaci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Loukaci more than expected).

Fields of papers citing papers by Ali Loukaci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Loukaci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Loukaci. The network helps show where Ali Loukaci may publish in the future.

Co-authorship network of co-authors of Ali Loukaci

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Loukaci. A scholar is included among the top collaborators of Ali Loukaci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Loukaci. Ali Loukaci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liu, Wang‐Qing, Yves Lepelletier, Matthieu Montès, et al.. (2017). NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model. Cancer Letters. 414. 88–98. 32 indexed citations
2.
Dao, Pascal, Rafika Jarray, Johanne Le Coq, et al.. (2013). Synthesis of novel diarylamino-1,3,5-triazine derivatives as FAK inhibitors with anti-angiogenic activity. Bioorganic & Medicinal Chemistry Letters. 23(16). 4552–4556. 57 indexed citations
3.
Nakib, Samir, et al.. (2012). N-Carbamoylputrescine, a citrulline-derived polyamine, is not a significant citrulline metabolite in rats. Analytical Biochemistry. 423(1). 54–60. 1 indexed citations
4.
Jarray, Rafika, Barbara Allain, Lucia Borriello, et al.. (2011). Depletion of the novel protein PHACTR-1 from human endothelial cells abolishes tube formation and induces cell death receptor apoptosis. Biochimie. 93(10). 1668–1675. 51 indexed citations
5.
Goddard, Mary‐Lorène, Ali Loukaci, Odile Mondésert, et al.. (2009). 5-Substituted [1]pyrindine derivatives with antiproliferative activity. European Journal of Medicinal Chemistry. 45(3). 896–901. 6 indexed citations
6.
Fourmy, Dominique, et al.. (2006). Hydroxyl Substitution Studies at the 5″‐Position in the Neomycin B Series: Introduction of a Phtalimide Group Under Mitsunobu Reaction Conditions. Synthetic Communications. 36(4). 487–493. 5 indexed citations
7.
Fourmy, Dominique, et al.. (2005). Introduction of a substituent at the 5″-position of N-Boc neomycin B under Mitsunobu reaction conditions. Organic & Biomolecular Chemistry. 3(11). 2064–2064. 7 indexed citations
8.
Sartillo‐Piscil, Fernando, et al.. (2005). Toward a novel series of furanopyrimidine nucleoside analogues. Tetrahedron Letters. 46(38). 6511–6514. 6 indexed citations
9.
Loukaci, Ali, Guilherme Ramos da Silva Muricy, Jean‐Paul Brouard, et al.. (2004). Chemical divergence between two sibling species of Oscarella (Porifera) from the Mediterranean Sea. Biochemical Systematics and Ecology. 32(10). 893–899. 15 indexed citations
10.
Loukaci, Ali, et al.. (2001). Coscinosulfate, a CDC25 phosphatase inhibitor from the sponge Coscinoderma mathewsi. Bioorganic & Medicinal Chemistry. 9(11). 3049–3054. 35 indexed citations
11.
Pedras, M. Soledade C., Sabine Montaut, Yiming Xu, Abdul Q. Khan, & Ali Loukaci. (2001). Assembling the biosynthetic puzzle of crucifer metabolites: indole-3-acetaldoxime is incorporated efficiently into phytoalexins but glucobrassicin is not. Chemical Communications. 1572–1573. 22 indexed citations
12.
Loukaci, Ali, Valérie Bultel‐Poncé, Arlette Longeon, & Michèle Guyot. (2000). New Lipids from the Tunicate Cystodytes cf. dellechiajei, as PLA2 Inhibitors. Journal of Natural Products. 63(6). 799–802. 38 indexed citations
13.
Loukaci, Ali, Oliver Kayser, K. U. Bindseil, et al.. (1999). New Trichothecenes Isolated from Holarrhena floribunda. Journal of Natural Products. 63(1). 52–56. 51 indexed citations
14.
Jannet, Hichem Ben, et al.. (1999). Neo-clerodane diterpenoids from Ajuga pseudoiva leaves. Phytochemistry. 52(8). 1541–1545. 25 indexed citations
15.
Loukaci, Ali, Michèle Guyot, A. Chiaroni, & C. Riche. (1998). A New Indole Alkaloid from the Marine Tunicate Dendrodoa grossularia. Journal of Natural Products. 61(4). 519–522. 20 indexed citations
16.
Pedras, M. Soledade C., et al.. (1998). The cruciferous phytoalexins brassinin and cyclobrassinin are intermediates in the biosynthesis of brassilexin. Bioorganic & Medicinal Chemistry Letters. 8(21). 3037–3038. 15 indexed citations
17.
Loukaci, Ali & Michèle Guyot. (1996). Revised Assignments of the13C NMR Spectra of Grossularine-1 and -2 Using 2D Heteronuclear1H-13C Correlations. Magnetic Resonance in Chemistry. 34(2). 143–145. 7 indexed citations
18.
Zèches, Monique, et al.. (1995). Alkaloids from Leaves and Stem Bark ofErvatamia corymbosa. Planta Medica. 61(1). 97–97. 4 indexed citations
19.
Loukaci, Ali & Michèle Guyot. (1994). Trikendiol, an unusual red pigment from the sponge Trikentrion loeve, anti-HIV-1 metabolite. Tetrahedron Letters. 35(37). 6869–6872. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lianne M. McHardy Breakdown of academic impact, for papers by Masahide Amemiya Breakdown of academic impact, for papers by Isao Uno Breakdown of academic impact, for papers by Klaus Feussner Breakdown of academic impact, for papers by Christos Roussakis Breakdown of academic impact, for papers by M. Teresa García‐López Breakdown of academic impact, for papers by Kathryn M. Marshall Breakdown of academic impact, for papers by Luke Esau Breakdown of academic impact, for papers by A Matsuzaki Breakdown of academic impact, for papers by Koichi Nakae
Rankless by CCL
2026